Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Treasury Shares (2023 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Treasury Shares for 6 consecutive years, with $5.2 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 12.39% to $5.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.2 million through Dec 2025, up 12.39% year-over-year, with the annual reading at $5.2 million for FY2025, 12.39% up from the prior year.
  • Treasury Shares for Q4 2025 was $15.5 million at Lexicon Pharmaceuticals, roughly flat from $15.5 million in the prior quarter.
  • The five-year high for Treasury Shares was $16.5 million in Q1 2025, with the low at $867973.0 in Q2 2023.
  • Average Treasury Shares over 3 years is $7.8 million, with a median of $5.0 million recorded in 2023.
  • The sharpest move saw Treasury Shares skyrocketed 59.97% in 2024, then increased 12.39% in 2025.
  • Over 3 years, Treasury Shares stood at $2.9 million in 2023, then surged by 59.97% to $4.6 million in 2024, then increased by 12.39% to $5.2 million in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $5.2 million, $5.2 million, and $5.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.